Our team expanded non-sterile product development capabilities by adding a new lab with hybrid environment. This new lab will benefit clients to take advantage of pilot scale manufacturing or conduct DOE studies to understand the processes better before getting into clinical batch manufacturing which will reduce the cost of the process and adds higher flexibility. In spring of 2024 we opened a new lab to accommodate the expanding capabilities.